Home » News
May 20, 2020
Saline nasal irrigation and gargling a new treatment option for COVID-19 In a recent study that was published in nature Journal and journal of global health(1)(2); researchers found that saline solution (NaCl) has an antiviral effect that works across viral types including corona virus infections. Researchers also found that saline nasal irrigation and gargling may have a role to play in reducing symptoms and duration of illness in COVID-19. These Impressive results were reached after the...
February 19, 2020
Amman pharmaceutical industries (API) – one of the fastest growing companies in the region – have officially announced the launching of a group of its high quality products in Uzbekistan markets through a distinguished ceremony in Tashkent in collaboration with its official partners. Uzbekistan is considered one of the most important countries in Central Asia region which is considered by API a high potential market regarding expansion and launching products. API is highly committed to its...
October 28, 2019
, ,
As Breast Cancer Awareness Month nears its end, Amman Pharmaceutical Industries is encouraging its family, and everyone around the world to understand the importance of breast awareness, education, and research. Breast Cancer Awareness Month, marked in countries across the world every October, helps to increase attention and support for the awareness, early detection and treatment as well as palliative care of breast cancer. Jordan Breast Cancer Program #JBCPJordan شاركت عائلة عمان للصناعات...
September 24, 2019
Amman Pharmaceutical Industries Company (API) launched its new product, Apisal sparkling nasal spray in a special scientific event that was organized last Monday night at the Fairmont Amman Hotel in cooperation with the Society of Ear Nose and Throat (ENT). During this scientific event Professor Stanley Lech introduced the features and therapeutic benefits of this new product, which is considered a revolution in the field of cleansing saline sinuses and nasal sprays, also clarified the...
July 21, 2019
, , , , , , ,
Sunday July 21st, 2019 In cooperation with the Jordanian Society of Ophthalmology, Amman Pharmaceutical Industries launched its new product “IMOX” Eye drop in an event that was held at Fairmont Amman Hotel. The company was honored to host a valuable number of attendees from the top Ophthalmologists in Jordan from all sectors (Privet sector, DRMS and MOH) who presented and discussed latest scientific topics regarding " Management Options in Microbial Keratitis: from the clinic to the theatre"...
April 4, 2019
We are always proud of being an effective player in the dynamic pharmaceutical sector in Jordan and highly appreciate USAID Jordan Competitiveness Program continuous support of our industry and its quest for growth #jordan #pharmaceuticalindustry #proudjordanian #usaid * Below is a link for USAID reportage about Jordan Competitiveness Program
October 18, 2018
Doctor Fadi Al-Atrash (General Manager) participated in a Meeting at Jordan Chamber Of Industry for Pharmaceutical Industries and Medical Supplies Sector. The meeting discussed the challenges that face exports to Iraq and Sudan.
February 16, 2016
Dry Eye and related irritations is one of the most widely spread problems in the MENA region and API is very proud to introduce a relief for it in the form of Hyaluronic Acid single dose units.
March 3, 2014
Amman Pharmaceutical Industries was honored today by the visit of his Excellency Prof. Nidal Katamine, Minister of Laour & Tourism. His Excellency toured our facilities and commended our operations, our staff, and our high quality manufacturing capabilities.  We thank his Excellency for his attentive visit and words of encouragement that will surely solidify our committment to raise our country's status in the international pharmaceutical arena further into the future. 
February 7, 2012
AMMAN // Fadi Al Atrash seemed destined for the pharmaceutical sector from a young age. After all, his grandfather, father and brother worked in the industry, and when he was just 12, Mr Al Atrash's father launched Amman Pharmaceutical Industries. The business specialises in producing "niche" medicines, such as eye and nose drops, and started out in 1989 with about 30 employees and just 200,000 Jordanian dinars (Dh1 million) of annual revenue. Since then the company has grown, along with Jordan...